Drug-resistant tuberculosis (TB) is estimated to cause 13% of all antimicrobial resistance-
attributable deaths worldwide and is driven by both ongoing resistance acquisition and …

The presence and consequences of resistance to drugs used for the treatment of
tuberculosis have long been neglected. The recent detection and recognition of widespread …

Drug-resistant tuberculosis (DR-TB) is challenging to diagnose, treat, and prevent, but this
situation is slowly changing. If the world is to drastically reduce the incidence of DR-TB, we …

Highlights•Management of tuberculosis is complicated by high levels of drug resistance in
some regions of the world.•Increasingly, molecular diagnostics are being used for resistance …

Even in the 21st century, we are losing the battle against eradication of tuberculosis (TB). In
2015, 9.6 million people were estimated to have fallen ill with TB, of which 1.5 million people …

Drug-resistant tuberculosis is a threat to tuberculosis control programs and community
health. This growing problem mirrors the increasing incidence of tuberculosis in general …

The emergence of antimicrobial resistance against Mycobacterium tuberculosis, the leading
cause of mortality due to a single microbial pathogen worldwide, represents a growing threat …

Drug-resistant TB originates from different human errors, including misuse of anti-TB drugs
and other reasons related to prescribers, patients and drug producers. Although there is an …

Over the past 7 decades, Mycobacterium tuberculosis has developed resistance to virtually
every new drug used to treat tuberculosis, resulting recently in the global emergence of …

Drug resistant tuberculosis contributes significantly to the global burden of antimicrobial
resistance, often consuming a large proportion of the healthcare budget and associated …